STAT3 and T-cell large granular lymphocyte leukemia: STAT3 mutations have been discovered in 40% of patients with T-cell large granular lymphocytic leukemia (T-LGL), a cytotoxic T-cell malignancy that is often associated with autoimmune diseases [38].